A Clinical Trial of TQB2450 Injection Combined With AL2846 Capsules in Patients With Advanced Solid Tumors
Clinical trial NCT06116240 · UNKNOWN
Trial details
- NCT number
- NCT06116240
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-02
- Primary completion
- 2023-12-01
- Enrollment
- 135
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.